Humer Franz B

CIK 00015480723 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001548072

Recent Transactions

50 trades

Award
Allogene Therapeutics, Inc.$ALLO
Restricted Stock Unit
2025-06-18+95,400→ 95,400 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2024-12-05$2.16/sh−9,221→ 307,507 total
Award
Allogene Therapeutics, Inc.$ALLO
Common Stock
2024-06-05+61,475→ 316,728 total
Award
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to buy)
2024-06-05+95,541→ 95,541 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2024-05-30$2.34/sh−11,200→ 255,253 total
Award
Allogene Therapeutics, Inc.$ALLO
Common Stock
2023-06-13+74,561→ 266,453 total
Award
Allogene Therapeutics, Inc.$ALLO
Common Stock
2022-06-15+44,178→ 191,892 total
Award
Allogene Therapeutics, Inc.$ALLO
Common Stock
2021-06-10+16,498→ 147,714 total
Award
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-06-05+9,969→ 131,216 total
Award
Allogene Therapeutics, Inc.$ALLO
Common Stock
2019-06-06+16,377→ 121,247 total
Award
CITIGROUP INC$C
Common Stock
2019-04-01$63.05/sh+151.348→ 21,304.002 total
Award
CITIGROUP INC$C
Common Stock
2019-04-01$63.05/sh+14.692→ 2,668.812 total
Award
CITIGROUP INC$C
Common Stock
2019-02-14+600.692→ 2,654.12 total
Award
CITIGROUP INC$C
Common Stock
2019-01-02$58.01/sh+142.85→ 18,513.238 total
Award
CITIGROUP INC$C
Common Stock
2019-01-02$58.01/sh+36.21→ 4,692.845 total
Purchase
Allogene Therapeutics, Inc.$ALLO
Common Stock
2018-10-15$18.00/sh+30,000→ 30,000 total
Conversion
Allogene Therapeutics, Inc.$ALLO
Common Stock
2018-10-15+74,870→ 104,870 total
Conversion
Allogene Therapeutics, Inc.$ALLO
Series A Convertible Preferred Stock
2018-10-15−14,261→ 0 total
Award
CITIGROUP INC$C
Common Stock
2018-10-01$70.35/sh+117.006→ 18,370.388 total
Award
CITIGROUP INC$C
Common Stock
2018-10-01$70.35/sh+29.66→ 4,656.635 total
Award
CITIGROUP INC$C
Common Stock
2018-07-01$67.57/sh+21.848→ 4,626.975 total
Award
CITIGROUP INC$C
Common Stock
2018-07-01$67.57/sh+86.191→ 18,253.381 total
Award
CITIGROUP INC$C
Common Stock
2018-04-01$74.44/sh+77.879→ 18,167.191 total
Award
CITIGROUP INC$C
Common Stock
2018-04-01$74.44/sh+11.103→ 4,605.127 total
Award
CITIGROUP INC$C
Common Stock
2018-02-15+2,015.046→ 4,594.024 total
Award
CITIGROUP INC$C
Common Stock
2018-01-02$75.63/sh+58.852→ 13,953.542 total
Award
CITIGROUP INC$C
Common Stock
2018-01-02$75.63/sh+28.321→ 6,714.748 total
Disposition to Issuer
Kite Pharma, Inc.
Director Stock Option (Right to Buy)
2017-10-03$123.88/sh−20,000→ 0 total
Disposition to Issuer
Kite Pharma, Inc.
Director Stock Option (Right to Buy)
2017-10-03$88.79/sh−8,810→ 0 total
Disposition from Tender
Kite Pharma, Inc.
Common Stock
2017-10-03$180.00/sh−4,624→ 1,807 total
Disposition to Issuer
Kite Pharma, Inc.
Director Stock Option (Right to Buy)
2017-10-03$129.13/sh−7,000→ 0 total
Disposition to Issuer
Kite Pharma, Inc.
Common Stock
2017-10-03−1,807→ 0 total
Award
CITIGROUP INC$C
Common Stock
2017-10-01$67.95/sh+65.201→ 13,894.689 total
Award
CITIGROUP INC$C
Common Stock
2017-10-01$67.95/sh+31.376→ 6,686.427 total
Award
CITIGROUP INC$C
Common Stock
2017-07-01$62.77/sh+35.188→ 13,829.488 total
Award
CITIGROUP INC$C
Common Stock
2017-07-01$62.77/sh+16.933→ 6,655.051 total
Award
Kite Pharma, Inc.
Common Stock
2017-06-20+2,410→ 6,431 total
Award
Kite Pharma, Inc.
Director Stock Option (Right to Buy)
2017-06-20+8,810→ 8,810 total
Award
CITIGROUP INC$C
Common Stock
2017-04-01$61.11/sh+36.043→ 13,794.3 total
Award
CITIGROUP INC$C
Common Stock
2017-04-01$61.11/sh+10.683→ 6,638.118 total
Award
CITIGROUP INC$C
Common Stock
2017-02-16+2,549.546→ 6,627.435 total
Award
CITIGROUP INC$C
Common Stock
2017-01-03$58.65/sh+19.261→ 7,077.497 total
Award
CITIGROUP INC$C
Common Stock
2017-01-03$58.65/sh+29.279→ 10,758.648 total
Award
CITIGROUP INC$C
Common Stock
2016-10-01$47.31/sh+36.17→ 10,729.369 total
Award
CITIGROUP INC$C
Common Stock
2016-10-01$47.31/sh+23.794→ 7,058.236 total
Award
CITIGROUP INC$C
Common Stock
2016-07-01$45.02/sh+11.866→ 10,693.199 total
Award
CITIGROUP INC$C
Common Stock
2016-07-01$45.02/sh+7.806→ 7,034.442 total
Award
Kite Pharma, Inc.
Common Stock
2016-06-01+1,950→ 4,021 total
Award
Kite Pharma, Inc.
Director Stock Option (Right to Buy)
2016-06-01+7,000→ 7,000 total
Award
CITIGROUP INC$C
Common Stock
2016-04-01$42.10/sh+12.674→ 10,681.332 total

Companies

Recent Filings

Address

C/O CITIGROUP INC., CORPORATE LAW DEPT. 425 PARK AVENUE, 2ND FLOOR

NEW YORK, NY, 10043

View on SEC.gov